Bioequivalence study of cyclosporine in renal transplant recipients

PREGNANCY IN RENAL TRANSPLANT RECIPIENTS

 ABSTRACT Background: Correction of the uremic state by a functioning allograft often restores fertility in women of reproductive age. The rate of fertility significantly differs between industrial countries, developing and middle east countries. On the other hand the results of pregnancy in Kidney Transplantation (KTP) patients are significantly better than hemodialysis patients, and pregnancy...

Histopathologic evaluation of Verrucous skin lesions in renal transplant recipients

Background: Warts are common in renal allograft recipients (RAR) with reported incidence of 24% to 100%. These patients also demonstrate an accelerated malignant transformation of warts. Although in immunocompetent patients, the histology of common warts is quite predictable, this is not so in RAR. Objective: The purpose of this study was to evaluate the histopathologic findings of warty lesion...

dyslipidemia in renal transplant recipients treated with cyclosporine a

Natural killer cell activity in renal transplant recipients receiving cyclosporine.

Normal subjects (n = 11) had a mean circulating natural killer (NK) cell activity of 188 lytic units per 10(7) peripheral mononuclear blood leukocytes. This activity was significantly enhanced by in vitro incubation with 500 U of alpha-interferon (+207 lytic units). The mean NK activity of renal transplant recipients on azathioprine (n = 17) or on cyclosporine (n = 17) studied at various times ...

Dyslipidemia in Renal Transplant Recipients Treated With Cyclosporine A

Death with a functioning graft is the most common reason for renal transplant loss, and cardiovascular disease is the leading cause of mortality. Dyslipidemia is a risk factor for cardiovascular disease in the general population, and is common after renal transplantation. Despite the fact that the relationship between dyslipidemia and cardiovascular mortality has not been proven in transplant r...